c-Myc is a transcriptional activator implicated in the control of cell proliferation, dierentiation and transformation, but is also involved in the regulation of programmed cell death, apoptosis. Despite intensive research, the molecular mechanisms by which c-Myc triggers and executes cell death remain still elusive. Here, we made use of Rat 1A MycER cells expressing a conditionally active c-Myc protein and tested ®rst the hypothesis that ornithine decarboxylase (ODC), which is a transcriptional target of c-Myc, were a mediator of cMyc-induced apoptosis. However, our results show that the activity of ODC is not required for the c-Mycmediated apoptosis to occur in these cells. We also found that the expression of p53, p21
Introduction c-Myc is a transcription factor which has a transactivation domain in the amino-terminus and a basic helix ± loop ± helix ± leucine zipper (bHLH/LZ)-motif in the carboxy-terminus for dimerization and binding to DNA. It associates with a related bHLH/LZ protein Max (Blackwood and Eisenman, 1991) and the heterodimer can bind to a consensus nucleotide sequence CACGTG and transactivate arti®cial gene promoters (Amati et al., 1993; Kretzner et al., 1992) and normal cellular genes (Bello-Fernandez et al., 1993; Benvenisty et al., 1992; Eilers et al., 1991; Galaktionov et al., 1996; Reisman et al., 1993) . Abundant evidence indicates that c-Myc is an important regulator of cell proliferation, differentiation and transformation. Upon a mitogenic stimulus quiescent cells expressing low levels of c-Myc enter the cell cycle and this transition is accompanied by a rapid induction of c-Myc activity (Kelly et al., 1983) . Enforced expression of c-Myc alone is sucient to push established cell lines into cycle (Eilers et al., 1991) and inhibition of c-Myc activity results in cell cycle arrest (HeikkilaÈ et al., 1987) . However, under certain circumstances an increased expression of c-Myc can also lead into cell death, apoptosis (Askew et al., 1991; Evan et al., 1992; Harrington et al., 1994) .
A lot of eort has been dedicated to ®nd out how c-Myc causes apoptosis. It has been shown that the dimerization of c-Myc with Max is necessary for apoptosis (Amati et al., 1993; Bissonnette et al., 1994) suggesting that a change in the expression of c-Myc target genes is needed, but, on the other hand, c-Myc-induced apoptosis has been demonstrated to occur without ongoing transcription . The apoptotic process initiated by c-Myc can be inhibited by some cytokines (Harrington et al., 1994) and the expression of the anti-apoptotic protein Bcl-2 has been found to rescue cells from c-Mycinduced apoptosis (Bissonnette et al., 1992; Fanidi et al., 1992) . Expression of c-Myc is also known to cause changes in the expression of some cyclins and in the activity of cyclin dependent kinases (Cdks) (Barrett et al., 1995; Jansen-DuÈ rr et al., 1993; Steiner et al., 1995) . Whether these protein alterations are directly mediated by c-Myc activity or are consequences of the transitions in the cell cycle accomplished by some other means of c-Myc, and their signi®cance for apoptosis, is unknown. However, the expression of cyclin A alone has been found to trigger apoptosis (Hoang et al., 1994) .
The tumor suppressor p53 appears to be required for apoptosis in a wide range of systems as evidenced by studies using temperature-sensitive p53-alleles and transfections of p53 into p53-negative cells (Ryan et al., 1993; Shaw et al., 1992; Yonish-Rouach et al., 1991) . However, data about the possible involvement of p53 in c-Myc-induced apoptosis are rather inconclusive: some reports demonstrate that wild-type p53 is required for c-Myc-induced apoptosis (Hermeking and Eick, 1994; Wagner et al., 1994) but also p53-independent mechanisms clearly exist (Lotem and Sachs, 1995; Sakamuro et al., 1995) . p53 is known to regulate transcription of the Cdk inhibitor p21 gene, and the gene encoding Bax protein with an ability to promote apoptosis (El-Deiry et al., 1993; Miyashita and Reed, 1995) , and to negatively regulate transcription of the anti-apoptotic bcl-2 gene (Miyashita et al., 1994) . However, in some cells p53 dependent apoptosis can evidently occur in the absence of transcriptional activation of p53-target genes (Brugarolas et al., 1995; Caelles et al., 1994; Wagner et al., 1994) . So far, of the genes known to be directly regulated by c-Myc at the transcriptional level, only ornithine decarboxylase (odc) (Bello-Fernandez et al., 1993; PenÄ a et al., 1993; Wagner et al., 1993) , cdc25A (Galaktionov et al., 1996) , and eukaryotic inititation factor 4E (elF4E) (Jones et al., 1996) are associated with positive regulation of cell growth, and potentially involved in apoptosis. ODC is the key regulator of polyamine biosynthesis catalyzing the conversion of ornithine to putrescine, which is a precursor for the higher polyamines spermidine and spermine (for reviews see Heby and Persson, 1990; Pegg, 1986; Tabor and Tabor, 1984) . odc is an immediate early gene the expression of which shows a rapid but transient induction after a mitogenic stimulus but is permanently elevated in transformed cells. The enzymatic activity of ODC is indispensable for cell growth for without polyamines cells will eventually stop dividing and die (Pohjanpelto et al., 1985) . Further, we and others have shown that ODC has oncogenic properties (Auvinen et al., 1992; Cliord et al., 1995; Megosh et al., 1995; Moshier et al., 1993) . Recently, also some information on the possible involvement of ODC and polyamines in apoptosis has been obtained (Askew et al., 1991; Desiderio et al., 1995; Packham and Cleveland, 1994; Poulin et al., 1995; Tobias and Kahana, 1995) .
The ultimate biochemical mechanisms and executioners of the apoptotic cell death triggered by c-Myc remain, however, still elusive. Current evidence indicates that proteases could be central components of cell death machinery in various forms of apoptosis. Cloning and characterization of the nematode celldeath gene ced-3 revealed that its product is related to mammalian interleukin-1b-converting enzyme (ICE), an aspartate-speci®c cysteine protease processing prolL-1b to an active cytokine. Although initially suggested, ICE proved not to be the functional mammalian counterpart of CED-3. Currently, nine additional members of the ICE/CED-3-family of cysteine proteases, called caspases, (ICE rel (Boldin et al., 1996; Darmon et al., 1995; Duan et al., 1996a,b; Fernandes-Alnemri et al., 1995a,b; Gu et al., 1995; Lazebnik et al., 1994; Lippke et al., 1996; Muzio et al., 1996; Nicholson et al., 1995; Srinivasula et al., 1996b; Tewari et al., 1995) . Of these, Caspase-3 and Mch3/ Caspase-7 seem to be the best candidates for the mammalian cell-death protease, but new family members may emerge. These proteases are thought to induce cell death by cleaving as yet unidenti®ed vital cellular proteins. One important substrate may be poly(ADP-ribose) polymerase (PARP), a nuclear enzyme involved in DNA repair and maintenance of genome integrity, and post-translational ribosylation of proteins (for a review see de Murcia and MeÂ nissierde Murcia, 1994) . PARP is speci®cally cleaved during apoptosis in several model systems and is a signature for the activation of these proteases (Darmon et al., 1995; Kaufmann et al., 1993; Tewari et al., 1995) . Other con®rmed substrates for CPP32 during apoptosis include the U1-70 kDa component of snRNP, the catalytic subunit of DNA-dependent protein kinase, protein kinase C d, the retinoblastoma gene product, D4-GDI (GDP dissociation inhibitor for the Rho family GTPases), sterol responsive element binding proteins and hnRNP C1 and C2 (for refs see Nicholson and Thornberry, 1997) .
In this study, we investigated the proposed role of ODC and other possible factors in mediating the c-Myc-induced apoptosis, and tried to elucidate the eventual mechanisms by which c-Myc induces cell death. We made use of a well-characterized Rat 1A MycER ®broblast cell line (Eilers et al., 1989) , where the activity of c-Myc and apoptosis can be triggered at will. Unexpectedly, we did not ®nd support for the idea that ODC and polyamines were mediators of cMyc-induced apoptosis in these cells. We did not either detect any appreciable changes in the expressions of p53, cyclins D1, E, A and B, the Cdk inhibitor p21, Bcl-2, Bax, Bcl-x L or Bad following the induction of apoptosis by c-Myc. But signi®cantly, we found a speci®c cleavage of PARP to occur as a consequence of the increased activity of c-Myc, suggesting that a caspase(s) is responsible for execution of the c-Myc induced apoptosis in Rat 1A MycER cells. Moreover, we found that CPP32/ Caspase-3 is likely to be one key apoptotic eector of c-Myc. A preliminary account of these results has been presented at the Cold Spring Harbour Meeting on Cancer Genetics and Tumor Suppressor Genes, 1996.
Results

Increased ODC activity is not required for c-Myc induced apoptosis in Rat1A MycER cells
Besides the well-established vital roles of c-Myc and ODC in cell growth, recent studies have shown that both of these proteins may also be involved in an opposite cellular process, induction of programmed cell death, apoptosis. As odc is a target gene for c-Myc (Bello-Fernandez et al., 1993; Wagner et al., 1993, our unpublished results), we wanted to test the hypothesis put forward in studies of hematopoietic cells that ODC is a mediator of c-Myc-induced apoptosis (Packham and Cleveland, 1994) . We used the ®broblastic Rat 1A MycER cell line expressing a chimeric c-Myc/estrogen receptor protein (Eilers et al., 1989) in which the activity of c-Myc can be controlled by estrogen at will. Upon the addition of the estrogen derivative bestradiol c-Myc becomes activated and the cells undergo apoptosis . In line with earlier reports (Harrington et al., 1994; KlefstroÈ m et al., 1994) , a disruption of cell integrity and detachment of the cells from the culture dishes started about 12 h after the induction of c-Myc activity in cultures with low serum (0.5% FCS) and the cell death was largely, but not totally, suppressed in the presence of 10% FCS (data not shown).
We ®rst tested the eect of c-Myc activation on the mRNA expression of ODC in the cells grown in low and high serum. Similarly to that reported for NIH3T3 MycER cells (Wagner et al., 1993) , we found an increase in the levels of ODC mRNA in the Rat 1A MycER cells cultured with 0.5% or 10% FCS after the induction of c-Myc activity. However, the transactivation of odc by c-Myc is much more potent in the presence of serum than under serum starved conditions (our unpublished results). Further, in the presence of 0.5% FCS only an about 2.5-fold, transient increase in the enzymatic activity of ODC was detected following the induction of apoptosis (Figure 1a) , which is marginal relative to the huge ODC inductions seen after various growth stimuli. This result is consistent with the idea that ODC upregulation is associated with the induction of cell proliferation following a mitogenic stimulus (e.g. serum) involving c-Myc activation, while in a situation of growth factor starvation and induction of cell death by c-Myc ODC is not critically involved. If this elevated ODC activity in the MycER cells were, however, responsible for the mediation of c-Mycinduced apoptosis, an inhibition of the activity of ODC should prevent the apoptotic process. An inhibition of the induction and the basal activity of ODC by the addition of the speci®c enzyme inhibitor DFMO ( Figure 1a) did not, however, block or interfere with the progression of apoptosis induced by c-Myc, as the percentage of the apoptotic cells with or without DFMO-treatment did not change ( Figure 1b) . Thus, the induction of ODC and de novo synthesis of polyamines are apparently not essential for apoptosis to occur. These data do not, however, totally rule out the possibility that polyamines were involved in the process, since mammalian cells have an active polyamine transport system which can be induced by c-Myc, and polyamines are present in FCS in the culture medium. Therefore, we also investigated the c-Myc-induced apoptotic process in cells cultured with or without DFMO and exogenous putrescine (0 ± 100 mM) added to the growth medium containing 0.5% dialysed FCS (free of polyamines). However, there were no signi®cant dierences in the rates of death between the cells under these conditions. Thus, we conclude that the enzymatic activity of ODC or the uptake of putrescine do not play important roles in cMyc-induced apoptosis in rat ®broblasts. In this context, it is noteworthy that of the other target genes of c-Myc, elF4E is also not involved in induction of apoptosis by c-Myc, and even blocks it (Polunovsky et al., 1996) , while cdc25A appears to be required for both cell growth and apoptosis (Galaktionov et al., 1996) .
Reactive oxygen radicals derived from polyamines or other sources do not play an important role in c-Myc-induced apoptosis Cells can regulate their intracellular concentration of polyamines through a catabolic pathway by a series of acetylation and oxidation reactions. So it is possible that cells could undergo apoptosis because of an increase in the level of reactive oxygen species (ROS) caused by an increased activity of the polyamine oxidase in the cells. We tested this hypothesis by inducing apoptosis in the MycER cells in the presence or absence of a speci®c polyamine oxidase inhibitor (MDL 72527). The presence of 25 ± 100 mM concentrations of the inhibitor did not reduce the percentage of the cells undergoing apoptosis (data not shown). Thus, the action of polyamine oxidase is not likely to mediate the apoptosis induced by c-Myc in rat ®broblasts. a b Figure 1 Induction of ODC enzymatic activity and eect of inhibition of ODC activity on viability of cells after c-Myc induced apoptosis. (a) Rat 1A MycER ®broblasts grown in 0.5% FCS were treated with 2 mM b-estradiol to activate c-Myc and enzymatic activity of ODC was measured as described in Materials and methods. Activity of ODC at dierent time points was compared to activity of uninduced control which was set to 1.0. Kinetics of ODC activity after induction of c-Myc activity is shown by the continuous line. At later time points the activity of ODC reached the level of the activity of uninduced cells and eventually (24 h) dropped below that as apoptosis proceeded further. ODC activity was almost totally inhibited by addition of 2 mM DFMO after induction of c-Myc activity (broken line). The results are means of two experiments. (b) Rat 1A MycER ®broblasts were activated by b-estradiol as above, activity of ODC was inhibited by 2 mM DFMO and cell viability was determined as described in Materials and methods. Means+s.d. of three experiments are shown, be=b-estradiol, pu=100 mM putrescine CPP32 in c-Myc-induced apoptosis A Kangas et al However, free oxygen radicals can arise in a variety of other intracellular oxidation reactions and ROS generation has been shown to be associated with apoptosis in several model systems, although not in all cases. Indeed, it is well known that antioxidants, like N-acetylcysteine and glutathione, have an antiapoptotic eect in many forms of apoptosis (Hockenbery et al., 1993; Jacobson and Ra, 1995) . Therefore, we wanted also to study whether the antioxidants could inhibit the apoptotic process triggered by c-Myc in the MycER cell line. Reduced glutathione (2 mM) or N-acetyl-L-cysteine (1 ± 5 mM) did not, however, appear to exert any signi®cant protective eect against the c-Myc-induced apoptosis (Figure 2) . Thus, the generation of reactive oxygen species is not likely to be the cause of cell death induced by c-Myc, but this has still to be veri®ed by direct analyses of the ROS levels in the cells.
p53, p21
waf1/cip1 , Bcl-2, Bax, Bad or Bcl-x L expression does not change during c-Myc-induced apoptosis in rat ®broblasts
To further try to elucidate the mechanisms of c-Mycinduced apoptosis in rat ®broblasts, we tested the possible involvement of the p53, Cdk inhibitor p21 and Bcl-2-family proteins in the death process. It is of note that activation of c-Myc in mouse ®broblasts produces p53 accumulation and p53 may mediate the apoptotic signal (Hermeking and Eick, 1994) , while in epithelial cells c-Myc can induce both p53-dependent and p53-independent pathways (Sakamuro et al., 1995) . First, we examined the mRNA expressions of p53, p21, Bcl-2, and Bax following the induction of apoptosis in Rat 1A MycER ®broblasts by Northern blot analysis. The mRNA levels of p53, Bcl-2 and Bax remained constant in the cells following the induction of apoptosis in the presence of 0.5% FCS or 10% FCS, and the mRNA level of p21 was undetectable (data not shown). Next, we studied the protein levels of p53, p21, Bcl-2, Bax, Bcl-x L , Bad and Bag by Western blot analysis. In accordance with the mRNA analyses, no appreciable changes were observed in the expressions of the p53, Bcl-2, and Bax proteins in the MycER cells following the induction of apoptosis by c-Myc (Figure 3) , and the levels of the p21 protein were again undetectably low. Also the level of Bcl-x L protein showed no changes during the apoptotic process, while the level of Bad, which is known to promote apoptosis (Yang et al., 1995), exhibited a slight decrease in repeated experiments. This may, however, be a secondary phenomenon to apoptosis, as Bad having two PEST-sequences (Yang et al., 1995) can be expected to be sensitive to degradation and turn over rapidly. No expression of Bag, a novel Bcl-2-binding protein (Takayama et al., 1995) , was detected. Also, we did not detect any clear electrophoretic mobility shifts in the Bcl-2 family member molecules indicative for possible phosphorylation changes (Gajewski and Thompson, 1996; Zha et al., 1996) . In addition, we found that the levels of the proliferating cell nuclear antigen (PCNA), involved in G1/S cell cycle transition and DNA replication, did not change (Figure 3 ).
Cyclins D1, E, A and B remain unchanged during c-Myc-induced apoptosis
As several recent reports suggest that many of the proteins regulating the cell cycle progression, such as cyclins, may also be involved in dierent forms of apoptosis we examined the expressions of cyclins D1 and E which regulate G1/S phase transition, cyclin A which is expressed in S phase, and cyclin B which is involved in mitotic control. However, as shown in Figure 4 , there were no signi®cant changes in the expression of these cyclins at the protein level in response to the c-Myc-induced apoptosis. Only a marginal increase in cyclin A was detected in some experiments, most probably as a result of the cells progressing into the S-phase. Consistent with our results, it has recently been reported that the levels of cyclin D1 and E (Steiner et al., 1995) or cyclin A (Rudolph et al., 1996) do not signi®cantly change following c-Myc activation. But, c-Myc has recently been found to induce an increase in the cyclin D1 and cyclin E-dependent kinase activities in Rat 1A MycER cells. However, these increases were much lower in serum-starved cells (i.e. under the apoptotic conditions) than in the presence of serum (Steiner et al., 1995) , making also the signi®cance of the cyclin-dependent kinases for apoptosis questionable.
Proteolytic cleavage of PARP occurs early in c-Myc-induced apoptosis
We then studied the possible involvement of caspases in c-Myc-induced apoptosis. As the proteolytic cleavage of the 116 kDa poly(ADP-ribose) polymerase (PARP) to an 85 kDa cleavage product is a signature for apoptosis occurring through activation of such proteases (Darmon et al., 1995; Kaufmann, 1989; Kaufmann et al., 1993; Lazebnik et al., 1994; Nicholson et al., 1995; Tewari et al., 1995) , we looked at the behavior of PARP in Rat 1A MycER cells following c-Myc activation (Figure 5a ). Interestingly, our immunoblotting experiments revealed that PARP becomes cleaved in this speci®c way. The 116 kDa protein was the predominant form in the cells until 4 h after the activation of c-Myc and the 85 kDa cleavage fragment began to appear 8 h after c-Myc induction, i.e. well before the morphologically detectable onset of apoptosis. At 16 ± 24 h most of the protein was cleaved. The cleavage was dependent on c-Myc activation as serum-starved, non-induced control cells did not display appreciable proteolysis of PARP during this time period (Figure 5b ). This was further con®rmed by our studies in Rat-1 MycER TM cell line in which the expression of c-Myc can be speci®cally induced by hydroxytamoxifen, and the possible transactivation eects of ER by estradiol avoided (Littlewood et al., 1995) . As depicted in Figure 5b , also in these cells the expression of c-Myc and induction of apoptosis resulted in the cleavage of PARP. The mere removal of serum (without the hydroxytamoxifen treatment) did not cause any cleavage of PARP (Figure 5b ), surprisingly not even following a prolonged starvation (72 h). To demonstrate that the cleavage of PARP as a consequence of c-Myc activation is not restricted to rat ®broblasts, we also analysed human epithelial (HeLa) cells transiently transfected to overexpress c-Myc in low serum. As shown in Figure 5c , c-Myc induced the cleavage of PARP also in the HeLa cells.
Having observed the early cleavage of PARP we wanted to examine how this cleavage of PARP relates temporally to the other known nuclear and cytoplasmic features of apoptosis. By TUNEL assay which measures the fragmentation of DNA we could detect a clear increase in apoptotic cells only 48 ± 72 h after the induction of apoptosis. Loss of membrane integrity as determined by trypan blue staining was detected after 16 ± 24 h, and practically all the cells were found to be dead by 72 h (Figure 6a ). Externalisation of phosphatidylserine, a phenomenon known to occur prior to plasma membrane disruption in apoptotic cells, was then measured and as shown in Figure 6b an initial, small increase in the number of apoptotic cells in response to c-Myc was detectable by this method at about 20 h. Of note, the percentage of cells exhibiting only apoptotic features (i.e. annexinV binding) is very low compared to the number of cells in which both apoptotic and necrotic or late apoptotic features (i.e. both annexinV and propidium iodide binding) are detected. This result implies that after the induction of c-Myc expression in Rat 1A MycER cells the phosphatidylserine externalisation precedes the total disruption of the plasma membrane integrity only by a very short time. Taken together, these results demonstrate that also in c-Myc-induced apoptosis one of the downstream eects is the speci®c cleavage of PARP and that the cleavage of PARP is a very rapid phenomenon preceding considerably the other observed nuclear and cellular features of apoptosis. Moreover, the extent of PARP breakdown shows that it is quantitatively a much more sensitive measure than the others in detecting cells undergoing apoptosis. It can be inferred from the extensive cleavage of PARP (almost complete by 24 h) that a very high percentage of the cells is undergoing apoptosis, which is important to know when considering how good a picture the whole cell population analysis (e.g. Western blottings) give of the apoptotic cells. It is also clear that the current methods used to detect apoptosis (TUNEL, DAPI [Hoechst 33342], annexinV stainings) may underestimate the number of apoptotic cells. Further, these assays can only detect apoptotic cells at a rather late stage, and are therefore of a limited value for the evaluation of the early triggering events. Also, our immunostaining of dierent proteins (p53, Bcl-2-family members, cyclins, etc.) in individual apoptotic cells versus the non-apoptotic cells as de®ned by these methods, did not provide any valuable information.
CPP32 is proteolytically cleaved to active subunits during c-Myc-induced apoptosis
Having found the speci®c cleavage of PARP, we asked the question whether the protease responsible for c-Myc-induced apoptosis is a previously known ICE-family member or a novel cysteine protease. We ®rst looked for the expression of the ICE-family members at the mRNA level. However, our Northern blot analyses with an ICE-probe under low stringency conditions revealed that the mRNA expressions of ICE-like proteases in the MycER cells were very low and remained constant following c-Myc activation. Then we analysed the protein expression levels and processing of the ICE homologues during the course of apoptosis. Since ICE itself cannot cleave PARP (Lazebnik et al., 1994), we investigated other members in the putative protease cascade. Immunoblotting of Ich-1 L did not reveal any changes in its expression or processing (Figure 7a ). But intriguingly, apopain/CPP32b was found to be cleaved from its 32 kDa inactive precursor form to the 17 kDa and 12 kDa subunits forming the active protease, the 17 kDa subunit of which is recognized by the antibody used ( Figure  7b ). Also minor intermediary cleavage products of CPP32 (Chinnayan et al., 1996; Fernandes-Alnemri et al., 1996; Martin et al., 1996; Quan et al., 1996) were detected. The kinetic analysis revealed that the processing of CPP32 occurred prior to the cleavage of the death substrate PARP.
Finally, we wanted to see whether the activation of caspase(s) is essential or not for the c-Myc-induced apoptosis to occur. Thus, we studied the eect of selective inhibitors of caspases, N-benzyloxycarbonylVal-Ala-Asp-¯uoromethylketone (Z-VAD-fmk) and N-benzyloxycarbonyl-Asp-Glu-Val-Asp -¯uoromethyl -ketone (Z-DEVD-fmk) on the activation of CPP32 and the cell death induced by c-Myc. These experiments showed that Z-VAD-fmk, a pan-inhibitor of caspases, added at 20 ± 50 mM or higher concentrations to the culture medium inhibited both the processing of CPP32 to the active p17 subunit (Figure 7c ) and the disruption of the cell morphology and detachment of the cells from the culture substratum (Figure 8a ). Also Z-DEVD-fmk, which preferentially inhibits the CPP32-like proteases, protected the cells from apoptosis, although less eciently than Z-VAD-fmk, the maximum viability being achieved by using 50 mM concentration of the inhibitor (Figure 8b ).
Discussion
Although our knowledge of the molecules involved in receptor (Fas/APO-1 and TNF-receptor)-mediated apoptosis has increased enormously during the last years, the signaling pathways critical for the nuclear oncoprotein-induced apoptosis have remained enigmatic. In this study we have examined both the possible mediators and the actual executioners of the c-Myc oncoprotein-induced apoptosis.
ODC is not a common mediator of c-Myc-induced apoptosis
It has been found that c-Myc complexed either with Max or another protein can bind to the consensus binding sites in the human and mouse ornithine decarboxylase (odc) genes and transactivate the gene (Bello-Fernandez et al., 1993; PenÄ a et al., 1993; Wagner et al., 1993, our unpublished results) . ODC is thereby a good candidate for a mediator of c-Myc function in the regulation of cell growth. Recently, ODC has also been suggested to be a mediator of cMyc-induced apoptosis in murine myeloid cells (Packham and Cleveland, 1994) . In the present study, we investigated whether the same is true for rat ®broblasts. However, we found only a very small and transient increase in the expression of ODC mRNA and in the activity of ODC following the activation of c-Myc in the Rat 1A MycER cells grown in low serum. It is hard to envision how such a small increase in the activity of ODC could cause apoptosis, as much larger¯uctuations of the enzyme activity and Persson, 1990; Pegg, 1986; Tabor and Tabor, 1984) . Also, if ODC were a mediator of c-Mycinduced apoptosis in these cells, an inhibition of the enzymatic activity of ODC should prevent the apoptotic process, a phenomenon not observed. We therefore conclude that an increase in ODC activity is not essential for c-Myc-induced apoptosis to occur in rat ®broblasts. Regarding the role of ODC, there is thus an apparent discrepancy between our results with rat ®broblasts and the data obtained from IL-3-dependent murine myeloid cells transfected with cMyc in which the cell death (following removal of IL-3) is inhibited, at least in part, by DFMO (Packham and Cleveland, 1994) . Cell type-speci®c dierences and dierent signaling pathways might be an explanation for the discrepant results, but, in any case, it looks apparent that ODC is not a general mediator of c-Myc-induced apoptosis. Nevertheless, an overproduction of ODC and polyamines may be involved in some forms of apoptosis (Poulin et al., 1995; Tobias and Kahana, 1995) and their mechanisms of action remain interesting to be elucidated. However, an accumulation of reactive oxygen radicals as a result of the polyamine oxidase activity as speculated (Packham and Cleveland, 1994) appears not to be responsible for the apoptotic eect of polyamines. Still confusingly, in rat thymocytes a decrease in the levels of polyamines has also been found to be associated with apoptosis (Desiderio et al., 1995) . Consequently, it appears that an imbalance in the concentrations of polyamines could be the contributing factor to apoptosis in some cases.
PARP is cleaved in c-Myc-induced apoptosis
A speci®c cleavage of the 116 kDa PARP to a 85 kDa proteolytic fragment has been found to occur in apoptosis in several model systems (Darmon et al., 1995; Kaufmann, 1989; Kaufmann et al., 1993 ; Nicholson et al., 1995; Tewari et al., 1995) . Interestingly, we found that the induction of c-Myc also provokes the characteristic cleavage of this death substrate, indicating that a caspase(s) is the actual eector of apoptosis induced by c-Myc. It is also evident from our data that a cysteine protease(s) is required for the apoptotic execution induced by c-Myc, as the cell-death process was suppressed by the addition of selective inhibitors of caspases to the culture. The fact that PARP is a proteolytic victim during the apoptosis initiated by such dierent inducers as c-Myc, cytotoxic drugs (Kaufmann, 1989; Kaufmann et al., 1993) , activated Fas and TNF receptors (Tewari et al., 1995) and granzyme B in Tc-lymphocyte mediated killing (Darmon et al., 1995) , indicates that PARP may be a very commonly used target of apoptosis in cells. It is noteworthy that the cleavage of PARP is evident already at 8 ± 16 h after the activation of c-Myc when only a minority of cells show apoptotic features detectable by the current assays or morphological characteristics of apoptosis, indicating that the cleavage of PARP can be used as a sensitive, early indicator of the apoptotic process. However, PARP is apparently not the only target in apoptosis (at least in animal development), because the PARP knock-out mice develop normally (MeÂ nissier de Murcia et al., 1997; Wang et al., 1995) , although, of note, these animals may have an increased sensitivity to DNA damage (MeÂ nissier de Murcia et al., 1997) . In fact, critical homeostatic and repair enzymes as well as structural proteins in both the cytoskeleton and nuclear scaolding are cleaved by caspases during apoptosis (Kumar and Harvey, 1995; Nicholson and Thornberry, 1997) .
CPP32 is a mediator of c-Myc-induced apoptosis
Of the 10 members of caspases thus far identi®ed, CPP32 is one of the strongest candidates for the mammalian cell-death-inducing protease cleaving PARP and other vital proteins. The results of our study strengthen this emerging concept. Interestingly, we found no changes in the expression or processing of Ich-1/Nedd2 during the c-Myc-induced apoptosis, while the inactive CPP32b precursor was speci®cally cleaved to the 17 kDa and 12 kDa subunits forming the active protease. A sequential activation model where proteolytically activated Nedd-2/Ich-1 would cleave and activate CPP32 and thus be upstream of CPP32 has been hypothesized (Kumar and Harvey, 1995; Tewari et al., 1995) . However, recently data showing the opposite, i.e. CPP32 being upstream of and cleaving Ich-1, has been presented (Harvey et al., 1996; Srinivasula et al., 1996a) . Anyway, in c-Mycinduced apoptotic cells there is not a protease ampli®cation cycle between Ich-1 L and CPP32, similar to that suggested for Mch2a and CPP32 (Srinivasula et al., 1996b) . Our observation that apoptosis was inhibited by Z-DEVD-fmk suggests that CPP32 or CPP32-like proteases play an important role in c-Myc-induced apoptosis. This is further supported by our recent ®nding that the known substrates of CPP32 become cleaved upon cMyc induction (Kangas and HoÈ lttaÈ , manuscript in preparation).
It is, however, evident that more than one protease becomes activated during the c-Myc-induced apoptosis, as we found the general caspase inhibitor Z-VADfmk to block the proteolytic processing of CPP32 to the active subunits and to cause a more potent inhibition/delay of cell death (McCarthy et al., 1997) than did Z-DEVD-fmk. Whether c-Myc triggers a sequential activation of a cascade of proteases branching at some point(s) or a set of parallel proteolytic pathways, possibly interacting with each other, remain to be seen. In any case, in c-Mycinduced apoptosis CPP32 cannot be the only caspase responsible for the degradation of the apoptotic targets, as for example lamins, which are speci®cally cleaved by Mch2 Takahashi et al., 1996) , become cleaved during the process (Kangas and HoÈ lttaÈ , manuscript in preparation). Unfortunately, due to the present unavailability of rat reactive antibodies we were not able to study the involvement of Mch-2 and other caspases, such as Mch3, Mch4, Mch5/MACH/FLlCE and Mch6, in the c-Mycinduced apoptosis in these cells.
In future studies it will be of interest to elucidate the regulatory mechanisms of CPP32 activation and what are its relevant downstream targets. It will also remain interesting to see whether the cleavage of CPP32 into the active subunits is a committed step in apoptosis or could a c-Myc overexpressing cell displaying CPP32 activation still be switched back into a proliferative state.
Materials and methods
Cell culture
The Rat 1A MycER (Eilers et al., 1989) and Rat-1 MycER TM (Littlewood et al., 1995) ®broblast cell lines expressing a conditionally active c-Myc-estrogen receptor chimera have been described previously. The cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 5% foetal calf serum (FCS) and antibiotics. For c-Myc activation and induction of apoptosis the cells were allowed to adhere to culture dishes in normal growth media overnight, washed with phosphate-buered saline (PBS), and induction media (DMEM without phenol red plus antibiotics) with 0.5% or 10% FCS together with 2 mM b-estradiol or 100 nM 4-hydroxytamoxifen was added. To inhibit the enzymatic activity of ornithine decarboxylase, a-difluoromethylornithine (DFMO), a speci®c and irreversible inhibitor of ODC, was added into the induction media at 2 mM concentration. For treatment of cells with antioxidants the cells were processed as described above and 2 mM glutathione or 1 ± 5 mM N-acetylcysteine was added into the culture media. To inhibit the activity of polyamine oxidase in the cells the induction media was supplemented with a speci®c inhibitor of polyamine oxidase, N,N'-bis(2,3-butadienyl)-1,4-butane-diamine (MDL 72527) at 10 ± 100 mM concentrations. DFMO and MDL 72527 were generously provided by Marion Merrell Dow Research Laboratories. To assess the role of caspases in the apoptotic process the cells were treated with cell penetrative inhibitors N-benzyloxycarbonyl-Val-Ala-Aspuoromethyl-ketone (Z-VAD-fmk) and N-benzyloxycarbonyl-Asp-Glu-Val-Asp-¯uoromethyl-ketone (Z-DEVD-fmk) (Enzyme System Products, CA, USA) at dierent concentrations. HeLa cells were cultured in DMEM with 5% FCS and antibiotics. 
Assays for apoptosis
Cells were analysed for apoptosis by determining the percentage of dead cells detatched from the substratum (KlefstroÈ m et al., 1994) . In addition, we performed terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) assays using the ApopTag TM In Situ Apoptosis Detection Kit (Oncor) and annexinV bindingbased phosphatidylserine externalization analyses by FACS using the Apoptosis Detection Kit (R&D Systems). Apoptotic nuclei were scored by DAPI staining.
ODC assay
The activity of ODC was measured as described previously (HoÈ lttaÈ et al., 1988) .
Transfection of HeLa cells
Subcon¯uent dishes of HeLa cells were rinsed with DMEM, and DMEM without antibiotics was used as the transfection media. 10 mg of pSV-Tc-Myc-plasmid was transfected by using Lipofectamine (Gibco BRL) according to the manufacturer's instructions. After transfection the cells were transferred to grow in DMEM supplemented with 0.1% FCS and antibiotics for 40 h.
Isolation of mRNA and Northern blotting
Poly (A) + mRNA of the cells was isolated with oligo(dT) cellulose, fractionated by agarose gel electrophoresis, transferred onto Hybond-N membrane and subjected to hybridization according to standard methods. a-[
32 P]dCTP DNA-probes were generated by using Multiprime DNA labeling system by Amersham. Inserts from the plasmids pODC16 and pCMV53wt were used as probes for the expression of ODC and p53, respectively. p21 waf1 mRNA levels were investigated by hybridizing the ®lters with cDNAs for mouse, rat and human p21. To study the expression of ICE family members, a 687 bp ICE DNA fragment was cloned by PCR with human monocyte cDNA as a template (primers forward: 5'-gactctcagcagatcaaac-3' and reverse: 5'-catcatcctcaaactcttc-3') and its identity was con®rmed by sequencing. The signals were detected by Kodak X-Omat AR-®lms with intensifying screens or using FUJIFILM Bio-I Imaging Analyzer BAS-1500 with Fuji Film Imaging Plates.
Western blotting and antibodies
Detergent soluble proteins of the cells were extracted essentially as described previously (HoÈ lttaÈ et al., 1993) by using 50 mM HEPES pH 7, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 1 mM AEBSF, 10 mg/ml approtinin, 10 mg/ml leupeptin, 1 mM orthovanadate as the extraction buer. For isolation of total cellular proteins the cells were resuspended into the extraction buer and sonicated. Protein samples in Laemmli sample buer were subjected to standard SDS ± PAGE-electrophoresis and transferred electrophoretically onto nitrocellulose ®lters (Bio Rad). The protein concentrations were determined by Bio Rad Protein Assay Kit. The ®lters were blocked and incubated with antibodies as described previously (HoÈ lttaÈ et al., 1993) . Enhanced chemiluminesence (Amersham, Pierce) was used for detection.
The following antibodies were used in immunodetection. Monoclonal anti-ICH-1 L (Nedd-2), monoclonal anti-Bad, polyclonal anti-Bcl-x, and polyclonal anti-Bcl-2 were purchased from Transduction Laboratories (USA), polyclonal Bax (P-19), polyclonal Bag-1 (C-16), polyclonal cyclin A (C-19), cyclin E (M-20), p21 (C-19 and M-19) and monoclonal PCNA from Santa Cruz, (USA), monoclonal cyclin B from Upstate Biotechnology (USA), pAb240 p53 from Pharmingen (USA) and peroxidase-conjugated secondary antibodies from DAKO (Denmark). The monoclonal a-PARP antibody C-2-10 was obtained from Dr Guy Poirier, Laval University, Quebec, (Canada) and polyclonal antiapopain/CPP32-p17 from Merck Frosst Centre for Therapeutic Research (Canada).
